Table 3.
Year | Team | Materials | Results |
---|---|---|---|
2018 | Reitmaier et al. [92] | Sr(II)-doted CPC scaffolds | Increased bone formation |
2019 | Li et al. [91] | Sr-hardystonite-gahnite bioactive ceramic scaffold | Induced substantial bone formation and defect bridging |
2020 | Chen et al. [86] | Sr-substituted biphasic calcium phosphate microspheres | Increased proliferation and osteogenic inductivity of BMSCs |
2020 | Zeng et al. [87] | Sr-substituted calcium phosphate silicate bioactive ceramic | Increased proliferation and ALP activity of BMSCs, inhibited osteoclast differentiation |
2020 | Tohidnezhad et al. [88] | Sr-composited β-tricalcium phosphate scaffold | Increased bone fracture gap bridging |
2020 | Tao et al. [89] | Aspirin-modified Sr-composited β-tricalcium phosphate | Increased osteogenic viability of MC3T3-E1 |
2020 | Wu et al. [31] | Sr-reinforced calcium phosphate hybrid cement | Increased ALP activity and osteogenic gene expression of BMSCs, and promoted bone regeneration |
2021 | Liu et al. [90] | Sr-substituted calcium silicate ceramics | Increased angiogenesis of BMSCs and accelerated bone regeneration |
ALP: alkaline phosphatase, BMSCs: bone marrow mesenchymal stem cells, CPC: calcium phosphate cements.